EDGAR Filing Documents for 0001415889-24-008495

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001415889-24-008495

Filing Date

2024-03-19

Accepted

2024-03-19 16:11:04

Documents

Period of Report

2024-03-15

Document Format Files

Seq	Description	Document	Type	Size
1		form4-03192024_080352.html	4
1		form4-03192024_080352.xml	4	4026
	Complete submission text file	0001415889-24-008495.txt		5554

Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103

Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312

Passage BIO, Inc. (Issuer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O PASSAGE BIO, INC. 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103

Business Address

Borthwick Kathleen (Reporting) CIK: 0001987062 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39231 | Film No.: 24763298